Shorter Antibiotic Courses May Be Better for Some Common Infections

New evidence suggests shorter antibiotic courses can work as well as longer ones for some common infections, challenging the old one-size-fits-all approach.

Details

For decades, patients were commonly told that finishing a full antibiotic course was essential, especially to prevent resistance. Newer evidence suggests the picture is more nuanced. A review covering more than 120 randomized trials found that shorter courses can be just as effective for many common bacterial infections and may reduce unnecessary antibiotic exposure. A 2026 study also found that nearly 90 percent of surveyed Americans still believe antibiotics should always be taken for a longer course, even when modern treatment guidance may recommend fewer days for certain infections. In the study, most respondents preferred a course of seven days or more for a hypothetical respiratory infection, while current guidance for some cases can call for only three to five days. The important distinction is that shorter evidence-based treatment does not mean patients should decide on their own when to stop taking an antibiotic. Current medical guidance remains to take antibiotics exactly as prescribed and discuss side effects or concerns with a healthcare professional. Some infections still require substantially longer treatment, including active tuberculosis. The broader shift is about matching treatment duration to the infection and the evidence rather than assuming that longer automatically means better. The research also highlights a communication problem: when medical guidance changes, people who grew up with the old message can understandably struggle to tell the difference between an updated prescription and permission to stop treatment whenever they feel better.

More videos